You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: infliximab increases response and remission rates in fistulising or treatment-resistant Crohn’s disease

https://doi.org/10.1136/ebm.7.6.186

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Source of funding: not stated.

    • For correspondence: Dr J K Marshall, McMaster University, Hamilton, ON, Canada. Email marshallj{at}mcmaster.ca.